Clinical Trials Logo

Clinical Trial Summary

The aim is to evaluate the feasibility of MFI-11, one of the comprehensive frailty tests, before EBUS-TBNA. The secondary aim is to evaluate the usefulness of MFI-11 in predicting complications in risk assessment before EBUS-TBNA.


Clinical Trial Description

Patients who will receive anesthesia are directed to the anesthesia clinic for preoperative evaluation. The primary purpose of preoperative assessment is to reduce perioperative morbidity and increase quality, reduce the cost of perioperative care, and ensure that the patient recovers as quickly as possible. In this context, the American Society of Anesthesiology (ASA) score is a classification that includes medical comorbidities. The classification system alone does not predict perioperative risks, but when combined with other factors (e.g. type of surgery, frailty) it may help predict perioperative risks. Age is not among the criteria in the ASA. In elderly patients, the indicator of decreased reserves and resulting weakness is called "frailty". Frailty is considered vulnerability and functional impairment caused by a significant decline in multiple systems. Objective, repeatable, and accepted scales must be used when evaluating frailty. MFI-11 is a strong predictor of mortality and postoperative complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06174168
Study type Observational [Patient Registry]
Source Ankara Ataturk Sanatorium Training and Research Hospital
Contact
Status Completed
Phase
Start date October 1, 2023
Completion date February 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06025071 - Residual Inflammatory Risk-Guided colcHicine in Elderly Trial Phase 4
Recruiting NCT05939674 - Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam N/A
Active, not recruiting NCT01862445 - Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
Completed NCT04065763 - Correlation of the Dural Sac Dimension With the Spread of Spinal Anesthesia
Completed NCT05103696 - A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients N/A
Active, not recruiting NCT05603364 - Effect of Postoperative Oral Carbohydrate Administration in Total Knee Arthroplasty Elderly Patients Early Phase 1
Terminated NCT03743961 - Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia
Completed NCT00773942 - Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries N/A
Terminated NCT03324711 - Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa) N/A
Completed NCT03211312 - Prediction Model of Cardiac Risk for Dental Extraction in Elderly Patients With Cardiovascular Diseases
Enrolling by invitation NCT04389008 - The Study of Anesthesia-related Risk Factors for Postoperative Death in Elderly Non-cardiac Surgery Patients in China
Completed NCT01851005 - Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients N/A
Recruiting NCT04442412 - Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy Phase 3
Completed NCT02873533 - Modification of the Quality of Life Based on Objective Geriatric Tests N/A
Completed NCT01599676 - Citrulline, Exercise Training and Muscle Strength in the Elderly N/A
Completed NCT04209738 - Changes in Cardiovascular and Sleep Quality Parameters Under Eurythmy Therapy and Tai Chi in Comparison to Standard Care - A Substudy of the ENTAiER Trial
Recruiting NCT04321265 - Outcomes and Prognostic Factors in COVID-19
Recruiting NCT05242692 - The Effects of Subanesthetic S-ketamine on Postoperative Delirium and Cognitive Function in the Elderly Undergoing Non-cardiac Thoracic Surgery Early Phase 1
Completed NCT03868007 - Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome N/A
Not yet recruiting NCT04254640 - Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML Phase 2